Freeman, S. D., Hills, R. K., Virgo, P., Khan, N., Couzens, S., Dillon, R., . . . Russell, N. H. (2018). Measurable Residual Disease at Induction Redefines Partial Response in Acute Myeloid Leukemia and Stratifies Outcomes in Patients at Standard Risk Without NPM1 Mutations. J Clin Oncol.
Styl cytowania ChicagoFreeman, Sylvie D., et al. "Measurable Residual Disease At Induction Redefines Partial Response in Acute Myeloid Leukemia and Stratifies Outcomes in Patients At Standard Risk Without NPM1 Mutations." J Clin Oncol 2018.
Styl cytowania MLAFreeman, Sylvie D., et al. "Measurable Residual Disease At Induction Redefines Partial Response in Acute Myeloid Leukemia and Stratifies Outcomes in Patients At Standard Risk Without NPM1 Mutations." J Clin Oncol 2018.